I-BASE HIV TREATMENT BULLETINImportant note: Information in this article was accurate in May 2005. The state of the art may have changed since the publication date.
Click here to return to I-BASE main menu
DonateNow
Print this Article


Editorial

HIV Treatment Bulletin - Vol. 6, No. 5, May 2005


The lead article in this issue provides an overview of lymphogranuloma venereum (LGV) and an update of recent cases in the UK.

Although this is still a rare incidence of LGV in gay men and MSM, the symptoms are extremely debilitating if untreated, and yet respond promptly to a simple course of antibiotics.

LGV was the focus of presentations at the BHIVA Spring conference in Dublin that stressed the importance of treatment for similar symptoms, even if a diagnosis is not confirmed or available. Awareness of the additional information and the surveillance system that was established at the end of 2004 by the Health Protection Agency is clearly important for all GU treating physicians.

This issue of HTB also includes excellent reports by Mark Mascolini from the Third European Resistance Workshop, that include important new data on the resistance profile of tipranavir.

His additional articles on the NATAP.org website, from which these articles are selected are highly recommended additional reading.

Distributed with this issue of HTB are the new i-Base guides to HIV, Pregnancy and Women’s Health; and Changing Treatment: what to do when your combination fails.

Both these guides are non-technical, easy-to-understand guides to treatment, written for HIV-positive people to be more informed about their treatment options.

All i-Base publications are free, please order them in bulk for your clients and patients using the fax-back order form on the back page, or easier still, directly from out new website.

050510
IB050605-01


©2005. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone / Firestone Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.